Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Ketamine and Prolonged Exposure for PTSD
NCT02727998Phase 2Terminated
- Sponsor
- Yale University
- Start
- Dec 2015
- Primary completion
- Nov 2021
- Modality
- Small Molecules
- Countries
- 1
01
Overview
A Phase 2 trial of ketamine in post-traumatic stress disorder (PTSD), sponsored by Yale University. Started Dec 2015; status: terminated.
02
Drugs
ketamine
03
Conditions
post-traumatic stress disorder (PTSD)
Beyond the preview
Go deeper on NCT02727998.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT02727998.